A cool path to disease deceleration
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
MIT PhD student Kathrin Kajderowicz is studying how hibernation-like states could pave the way for new hypothermic therapies.
A new study shows that truncated versions of the Tau protein are more likely to form the sticky filaments seen in the brains of people with Alzheimer’s disease.
MIT researchers characterize gene expression patterns for 22,500 brain vascular cells across 428 donors, revealing insights for Alzheimer’s onset and potential treatments.
Created by community organizer and MIT adjunct professor emeritus Mel King, the program continues to empower and connect changemakers.
Students, researchers, and actors don AGNES for a taste of the friction, frustration, and fatigue that older adults often experience.
“Single-cell profiling” is helping neuroscientists see how disease affects major brain cell types and identify common, potentially targetable pathways.
In people carrying APOE4, a key brain cell mismanages cholesterol needed to insulate neurons properly — another sign APOE4 contributes to disease by disrupting brain lipids.
MIT AgeLab co-hosts 10th anniversary celebration of Boston Bridge, a longtime collaborator offering development, networking, career growth, and mentorship in the field of aging.
Study indicates ailing neurons may instigate an inflammatory response from the brain’s microglia immune cells.
OMEGA scholarships encourage bonds between younger and older adults.
Mel King Community Fellows from MIT's Community Innovators Lab meet in Berlin to examine the German elder care model.
MIT alumni-founded WalkWise uses a motion-detecting device for walkers to allow family members and care professionals to monitor adults with mobility challenges.
Program supports family caregivers with dedicated service coordinators based on learning from MIT's AgeLab.
Targeting these circuits could offer a new way to reverse motor dysfunction and depression in Parkinson’s patients.
Projects from a new MIT urban studies and planning course speak to the impact of increased longevity on systems and markets.